Drug shortage
Ambrisentan Tablet · Apotex Corp.
FDA drug shortage · To Be Discontinued · updated Jan 14, 2025
Key facts
| Generic name | Ambrisentan Tablet |
|---|---|
| Proprietary name | Ambrisentan |
| Company | Apotex Corp. |
| Presentation | Ambrisentan, Tablet, 10 mg (NDC 60505-4553-3) |
| Dosage form | Tablet |
| Strength | 10 mg |
| Status | To Be Discontinued |
| Therapeutic category | Cardiovascular |
| Package NDCs | 60505-4553-3 |
| First posted | Jan 14, 2025 |
| Last updated | Jan 14, 2025 |
| Discontinued | Jan 14, 2025 |
At a glance
- 1–9 Package NDCs affected
- 1–9 FDA shortage records for this drug
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA drug shortages
The FDA Drug Shortages Database lists current and resolved shortages of drugs, with presentations, affected NDCs and reasons reported by manufacturers.
Source: U.S. Food and Drug Administration (FDA), Drug Shortages Database · Source date: